270-554-9412

Health Policy

Articles

N

National Drug Control Policy and Prescription Drug Abuse: Facts and Fallacies

N

How to Appeal Medicare Denial Download a pdf step-by-step guide through the appeals process

N

Medicare Parts A & B Appeals Process

N

Filing a Medicare Appeal

Related Links

N

New England Journal of Medicine

N

Health and Human Services (HHS)

N

Centers for Medicare And Medicaid Services (CMS)

N

DEA

Letters

N

SENT Comment Letter to Department of Heath and Human Services RE Draft Report on Pain Management Best Practices-Updates Gaps Inconsistencies and Recommendations

N

SENT Letter to Thomas Price Seema Verma Demetrios Kouzoukas CMS Centers for Medicare and Medicaid Services RE 1656-FC 5.18

N

SENT Comment Letter To CMS On HOPDs And ASCs CMS-1678-P 9.11.2017

N

SENT Letter to Congress Addressing the Opioid Crisis

N

SENT Comments on Docket No. CDC-2022-0024 – Proposed 2022 CDC Clinical Practice Guideline for Prescribing Opioids

Health Policy Regulations

N

Reframing Medicare Physician Payment Policy for 2019: A Look at Proposed Policy

N

Medicare Issues Proposed Rule for ASC’s Serving Medicare Patients

N

Texas Workers’ Compensation Regulations

N

DEA Practitioner’s Manual

N

Limit on Number of Buprenorphine Patients Per Physician

Our Board members

BOARD OF DIRECTORS

Laxmaiah Manchikanti, M.D | Paducah, KY

Chairman of the board and chief executive officer

Amol Soin,
MD | Centerville, OH

President

Mahendra Sanapati,
MD | Evansville, IN

Vice President

Where and when

Events

    Click Here For Upcoming Conferences